Background Sexual dysfunction (SD) is common in multiple sclerosis (MS), however, under-reported. Objective The aim of this study was to identify barriers faced by patients with MS and healthcare professionals (HCPs) in discussing SD. Methods This was a two-part prospective study carried out at a tertiary care centre. Patients with MS were surveyed using a 29-item questionnaire and SD was assessed using the MSISQ and ASEX questionnaires; depression screened with PHQ-2. HCPs were surveyed using a 23-item questionnaire. Results Seventy four patients (mean age 42.4 ± 10.7, 54 females) and 98 HCPs (mean age 45.8 ± 8.9, 90 females) participated. SD was significant, with primary (36.4%), secondary (27%) and tertiary (29.8%) contributory factors. Commonest barriers reported by patients were dominance of neurological symptoms (N = 30, 40.5%), presence of family or friends (N = 28, 37.8%), and not being asked (N = 25, 33.8%), while HCPs reported presence of family or friends (N = 34, 34.7%), lack of knowledge about SD (N = 30, 30.6%), and inadequate time during the consultation (N = 27, 27.6%). Conclusions Barriers to discussing SD are similar between patients and HCPs. The most common barriers are addressable through modifications in the clinic environment, raising awareness and providing training opportunities.
Introduction
Sexual dysfunction (SD) is commonly reported in multiple sclerosis (MS) . Reported rates range between 50-90% in men and 40-80% in women [1] . In the multidimensional model of SD, primary (changes in sexual functions due to lesions in nervous system), secondary (caused by neurological disability such as fatigue and spasms, or bladder/bowel incontinence) and tertiary (emotional and psychosocial changes as a result of MS) factors contributing to SD have been identified [2] . SD has been shown to correlate with duration and severity of disease [3] , neurological deficits [4] , lesion distribution on magnetic resonance imaging (MRI) [5] , as well as the presence of brain atrophy, quality of life (QoL) [6] and depression [7] . Treatment strategies exist for managing SD and interventions have been shown to be associated with an improvement in symptoms and QoL [8] .
However, screening for SD remains low and SD is often under-diagnosed in clinic [9] . Reasons for this are unclear; however, barriers to discussing SD are likely to exist. Studies in chronic medical illnesses have identified different barriers to a discussion including too little time for a discussion, feeling the patient is not ready, as well as lack of knowledge, awareness, confidence or training amongst healthcare professionals (HCPs) [10] and low level of awareness of later life sexual health issues [11] . Many of these barriers can 1 3 be addressed. Reluctance of patients in initiating a discussion about SD may arise from a variety of reasons such as a perception that HCPs may not be sufficiently experienced or mature to explore their problems, feelings of shyness and embarrassment, age and gender issues [12] .
Patients with neurological disease and their HCPs are likely to be experiencing similar barriers towards discussing SD, however, the additional aspect of chronic neurological disabilities and their management is likely to predominate during hospital visits. They are likely to be experiencing symptoms, however, these are not being addressed because of non-disclosure. The aim of this study was to identify barriers experienced by patients and HCPs. Recognising these barriers to help-seeking would help to facilitate the discussion of potentially amenable symptoms.
Materials and methods
This was a two-part prospective cross-sectional study carried out at a specialist tertiary care teaching hospital over 6 months. This service evaluation was reviewed and registered with the divisional Quality and Clinical Governance Department. Validated questionnaires evaluating barriers to discussing SD are lacking, and therefore, a literature search of studies evaluating barriers faced by patients and HCPs to discussing sexual dysfunction was performed using the search engine Pubmed of studies published in the English language till 2013 using the key words "sexual dysfunction", "attitudes", "healthcare professionals", "multiple sclerosis", "quality of life", and "questionnaires".
Part 1-survey of patients with MS
A bespoke 29-item questionnaire included possible barriers that were identified in the literature search [13] . Patients were asked to rate the relevance of the different barriers using a 5-point Likert scale (strongly disagree/disagree/neither agree or disagree/agree/strongly agree) (Supplementary Material 1). Space was provided for free text to add any additional factors that were perceived as being barriers but not listed in the questionnaire. The Arizona Sexual Experiences Scale (ASEX), a validated 5-item questionnaire which evaluates different domains of SD using a 5-point Likert scale [14] , and the Multiple Sclerosis Intimacy and Sexuality Questionnaire (MSISQ), a validated 15-item questionnaire which assesses primary, secondary and tertiary factors that contribute to intimacy and sexual dysfunction specifically in MS using a 5-point Likert scale, were also administered [2] . The Patient Health Questionnaire-2 (PHQ-2) was included to screen for depressive symptoms using a 4-point Likert scale [15] . Onset of SD and possible sources of help to address the problem, as well as co-morbidities such as lower urinary tract (LUT) and bowel symptoms, cardiovascular disease, gynaecological problems, and medication-use were enquired. The questionnaire was reviewed by five patients with MS attending the outpatient clinic and amended according to the feedback received.
Consecutive patients with MS between the age 16 and 65 who were sexually active, and attending the uro-neurology out-patient clinic and Queen Square Multiple Sclerosis Centre were invited to participate and complete the anonymised questionnaire. Questionnaires were handed in to one of the investigators or returned in the post using pre-stamped envelopes.
Patients reporting a history of a significant psychiatric disorder, MS relapse in the previous 4 weeks, substance abuse, or women either pregnant or having attained the menopause were excluded from the study.
Part 2-survey of HCPs
A bespoke 23-item questionnaire included possible barriers that were identified in the literature search [10, 16] . HCPs were asked to rate the relevance of the barriers using a 5-point Likert scale (strongly disagree/disagree/neither agree or disagree/agree/strongly agree) (Supplementary Material 2). Space was provided for free text to add any additional factors that were perceived as being barriers but not listed in the questionnaire.
The questionnaire was reviewed by 11 HCPs and amended according to the feedback received. The questionnaire was uploaded onto an online survey portal (http:// www.Surve yMonk ey.com) and was sent by email to 300 HCPs consisting of consultants, nurses, and physiotherapists on the electronic mailing list of the Multiple Sclerosis Trust who are involved in the care of MS patients.
Data was analysed using IBM SPSS Statistics, Version 14 (Armonk, NY: IBM Corp.) for descriptive statistics, and frequency tables. Student's t test was used to analyse perceived barriers according to gender.
Results

Part 1-survey of patients with MS
Seventy-four patients with MS (72.97% females (N = 54)) participated in the study, mean age 42. (Table 1) .
According to the PHQ-2 [15] , features of depression were noted in 23.0% (N = 17) patients, including little interest or pleasure in doing things (N = 11, 14.86%; females N = 7 (12.96%), males N = 4 (20%)) and feeling down, depressed or hopeless (N = 15, 20.27%, females N = 9 (16.66%), males N = 6 (30%)). Patients with higher scores on the MSISQ more often reported depressive symptoms on the following domains: muscle tightness or spasms (p = 0.023), bowel symptoms (p = 0.021), feeling of being less masculine or feminine due to MS (p = 0.027), fear of being rejected sexually because of MS (p = 0.008), worries about the inability to sexually satisfy the partner (p = 0.002) and lack of sexual interest or desire (p = 0.003).
All patients reported at least one barrier and the barriers are listed in order of prevalence in Table 2 . Additional barriers listed by patients were uncertainty how the nurse/ doctor would engage in a deeper discussion on bisexuality in a lesbian, gay, bisexual, and transgender (LGBT) relationship (n = 1), attaining the menopause (n = 1), perception that sexual problems were not issues discussed beyond a certain age (n = 1), perception that doctors were embarrassed or unsure about discussing sexual problems (n = 1), impact of sexual dysfunction on the spouse (n = 1) and the impact of fatigue on sexual performance (n = 1).
Patients preferred the following sources for seeking help: consultants (N = 43, 58.1%), nurses (N = 39, 52.7%), GPs (N = 38, 51.4%), MS charities (N = 28, 37.8%), another person with MS (N = 20, 27%), physiotherapist (N = 18, 24.3%), junior doctor (N = 10, 13.5%), the internet (N = 10, 13.5%), friends or relatives (N = 10, 13.5%).
Part 2-survey of HCPs
Ninety eight HCPs participated in the survey (91.8% (N = 90) females, mean age 45.8 ± 8.9 years) and comprised of nurses (N = 82, 83.7%), consultants (N = 7, 7.1%), therapists (N = 4, 4.1%) and others (N = 4, 4.1%). Mean duration since primary qualification was 23.3 ± 9.6 years.
All HCPs reported at least one barrier and these are listed in order of prevalence in Table 3 . There were no significant differences in perceived barriers between male and female HCPs. HCPs with more years of experience reported more confidence, awareness and knowledge when dealing with sexual issues. Their perception of the prevalence of sexual problems increases with years of experience, and they are more likely to initiate the conversation, discuss and follow a structured approach (Supplementary Material 3).
Barriers perceived by patients were compared with barriers perceived by HCPs (Tables 2, 3 ) and proposals to address the same are provided (Table 4) .
Most barriers were reported with similar prevalence. Barriers that were significantly more reported by patients were the perception of being pointless to raise SD as there was no treatment (p = 0.000), age gap between patient and HCP (p = 0.000) and perception that SD is not an MS-related problem (p = 0.000). Barriers that were significantly more reported by HCPs were presence of family or friends in the consultation room (p = 0.043), fear of appearing to be inappropriate (p = 0.001) and fear of offending (p = 0.000).
Discussion
The study aimed to evaluate perceived barriers to discussing sexual problems in an unselected take of patients affected by MS and HCPs involved in the care of patients. Through identifying barriers we hope to help address this potentially solvable issue [17] . Different dimensions of SD were explored and primary factors were found to be contributing to SD most commonly, followed by tertiary and secondary factors. Depressive symptoms were present in a substantial number of patients, and was associated with greater degree of SD, as well as with the presence of tertiary factors contributing to SD, followed by secondary and primary factors. Despite the high prevalence of SD reported in MS, SD was addressed in only a small number of patients at this tertiary-level teaching hospital, and was smaller than from previous studies elsewhere [13] . A few studies have evaluated barriers to discussing SD in different populations of HCPs and patients, and include the perception of general practitioners when seeing patients with cardiac disease, in cardiology practice [10, 16] , in the primary care setting [18] , amongst patients with MS [13] , amongst neurosurgical doctors when seeing patients with spinal disease [19] , patients with type 2 diabetes patients [20] , patients with cancer [21, 22] , oncology nurses [23] , and amongst patients with low back pain [24] . Possible barriers were selected following a review of these studies, and very few participants indicated additional barriers in the free text box, suggesting that barriers experienced are similar across different diseases. All patients and HCPs in the study recognised at least one barrier to discussing SD. Most barriers were reported with similar prevalence, and the order of prevalence was similar between the two groups. Several barriers were identified, however, none were reported in more than 50% of the respective group. One of the commonest barriers reported by patients was not being asked about sexual problems. It has been previously demonstrated that bladder and bowel symptoms were being ignored by medical staff [25] , and the results of this study suggests this extends to sexual dysfunction as well.
The presence of family or friends in the consultation room was frequently cited both by HCPs (n = 34, 34.7%) and patients (N = 28, 37.8%) as a barrier. The need for privacy is an important consideration when discussing this intimate problem, and is a consistent finding in different studies [26, 27] . Often a carer, friend or relative accompanies the patient which makes the topic difficult to address. Presence of family and friends was a barrier reported by women and men, however, in a sizeable number (N = 17, 23%) presence of another HCP in the room was also a barrier, indicative of the intimate nature of the conversation.
The limited time available in a consultation results in a prioritisation of symptoms for discussion. Previous studies have demonstrated that assessment of pelvic organ complaints are limited by time constraints and staff workloads, since clinic visits can be lengthy and pelvic organ complaints are not necessarily the primary aim of the visit [25] . 29.7% of the patients indicated that addressing sexual difficulties was a priority, and therefore, it would be appropriate to incorporate within the consultation a period of time without accompanying carers, partners or friends, where intimate matters could be addressed. Possibly using symptom check-lists filled in before the appointment so that HCPs are aware about the different symptoms that need to be discussed could help address this issue. Alternatively, the conversation may need to be staggered over several consultations to accommodate time to discuss this intimate topic, or joining up a doctor-led and nurse-led clinics so that sufficient time is available. Patients perceived that SD is not an MS-related problem and perceived age gap as a barrier compared to HCPs. HCPs should be aware of this and should strive to initiate the conversation whenever possible. Initiating the conversation on SD is beset with uncertainty however, not being asked was a barrier reported by 33.8% (N = 25) of patients. For a sizeable number, patient is expecting that the HCP should be initiating the discussion. Only 6% of patients have ever discussed their concerns with a medical professional or undergone sexual therapy [28] . Introducing the topic involves giving permission to the patient to bring up the topic through open-ended questions. The PLISSIT (permission, limited information, specific suggestions and intensive therapy) model which facilitates a structured approach to addressing SD has been advocated as a framework to help HCPs address the problem of sexual dysfunction [29] . As the initial step, giving permission to the patient to discuss SD in itself is quite helpful for both patient and HCP to help initiate the discussion, and to then take this further according to the requirements of the patient [29] . Being a sensitive matter, the discussion could be initiated around bladder and bowel complaints as a way of entry, to then bring up a discussion thereafter about more intimate problems such as sexual difficulties [30] .
More often women rather than men felt a discussion about SD was pointless. This reflects the current availability of treatment options regarding management of SD which are much more established in men than women [31, 32] . However, options for managing sexual dysfunction in women do exist and women should be aware where such information can be accessed. Greater awareness amongst patients that SD can occur as a result of MS or its related disability would help considerably to dispel notions and myths about SD, but also to help patients become more confident about addressing the topic. Patient information days and leaflets available through reputable organisations such as MS charities are an important resource for patients to utilise.
In clinical practice, poor communication with the HCP has been highlighted as a significant barrier to seeking help for SD. Absence of knowledge, confidence and comfort was previously reported in HCPs as barriers to the discussion about sexual functions [21] . 55% of males and 39% of female patients with MS were able to discuss their sexual difficulties with their health care professionals (HCPs) and low satisfaction rates were reported [13] . Lack of knowledge was cited by more than 30% of HCPs and could be addressed by improving knowledge and training in the evaluation and management of SD through study days and short spells of observer-ships in specialist units, training sessions in communication, and providing opportunities for further exposure in addressing sexual dysfunction and providing a framework for discussion according to the PLISSIT model [33, 34] . HCPs with more years of experience seem more skilled in addressing SD, however, due to small sample size and lack of statistical power further statistical analysis could not be performed.
Contrary to our expectations, only a small number of patients and HCPs reported language, religious, or cultural factors and gender as barriers to a discussion. The survey did not capture information about cultural and religious factors that could influence a discussion on SD [35] , however, the study was carried out at a centre that caters to a large multi-ethnic population. This would need to be evaluated in further studies.
The absence of a validated questionnaire to evaluate barriers necessitated designing a questionnaire based on the known barriers from the literature. The questionnaires were, however, reviewed by patients and HCPs, respectively, before use. Nevertheless, these results from a sizeable number of patients and HCPs provide preliminary information about possible barriers. The questionnaires should be validated so that a standardised assessment is possible across different centres and different neurological conditions. The validated questionnaire would serve to enhance awareness of the problems identified in this study. Future studies should be designed to explore in-depth these barriers to help-seeking perceived by patients and HCPs. Thematic-based interviews in the framework of a qualitative study would allow a comprehensive assessment of ways to address these different barriers. The results may not be generalisable across different societies as the perception of barriers is likely to by culturally influenced. Future studies should explore similarities and differences in perceived barriers across different populations.
In conclusion, several barriers to help-seeking for SD were identified, and these contribute to the under-reporting of this significant problem. Modifications in the clinic environment, raising awareness about SD amongst patients and providing training opportunities for HCPs will help address these different barriers, and thereby help narrow the treatment gap for this potentially amenable problem.
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